A Study to Evaluate the Efficacy and Safety of Orally Administered VX-01

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(26 sites)

United States

Retina-Vitreous Associates Medical Group, Beverly Hills, California

Stanford Byers Eye Institute, Palo Alto, California

California Retina Consultants- Santa Barbara, Santa Barbara, California

Florida Retina Institute - Jacksonville Southside, Jacksonville, Florida

Retina Associates, Elmhurst, Illinois

Cumberland Valley Retina Consultants, Hagerstown, Maryland

Erie Retina Research, Erie, Pennsylvania

Piedmont Eye Center, Lynchburg, Virginia

Australia

Eye Clinic Albury Wodonga, Albury, New South Wales

Retina And Eye Consultants Hurstville, Hurstville, New South Wales

Marsden Eye Specialists, Parramatta, New South Wales

Sydney Eye Hospital, Sydney, New South Wales

Sydney Retina Clinic, Sydney, New South Wales

Sydney West Retina, Westmead, New South Wales

University of the Sunshine Coast Clinical Trials (Birtinya), Birtinya, Queensland

Royal Adelaide Hospital, Adelaide, South Australia

Hong Kong

Prince of Wales Hospital The Chinese University of Hong Kong, Shatin

HKU Eye Centre, Wong Chuk Hang

Malaysia

University Malaya Medical Centre, Petaling Jaya, Kuala Lumpur Federal Territory of Kuala Lumpur

Hospital Pulau Pinang, George Town, Pulau Pinang

Hospital Shah Alam, Shah Alam, Selangor

Hospital Al-sultan Abdullah Uitm, Sungai Buloh, Selangor

Hospital Selayang, Selayang Baru Utara

South Korea

Seoul National University Bundang Hospital, Seongnam-si

Asan Medical Center, Seoul

Samsung Medical Center, Seoul